An interventional study of Zenicog;language rehabilitation program and Conventional language rehabilitation in Stroke, Aphasia and Speech Therapy, sponsored by Korea University Guro Hospital. Completed at 1 site in South Korea. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2026-10-01.
Sponsored by Korea University Guro Hospital · Not applicable, Interventional, and Treatment
Our study will provide precise and intensive speech rehabilitation treatment program to patients with speech disorders after stroke, and compare clinical evaluations with the conventional speech therapy patient group.
Clinical evaluation tools will be performed before and after the treatment for all patients
During the initial evaluation of this study, the patient's gender, age, and onset of stroke lesion occurrence are collected and a cognitive evaluation is performed. In addition, the K-Western Aphasia Battery for aphasia assessment tools(K-WAB) and Cerebral blood flow changes with near-infrared spectroscopy will be performed. All participants will be assigned to a test group or control group. In addition to the existing speech rehabilitation treatment, the test group will receive a speech rehabilitation program, and the control group will receive the same treatment as the existing speech rehabilitation treatment.
After treatment is completed, the K-WAB test and near-infrared spectroscopy will be performed again.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's enrollment of 20 is below the median of 49 across 6,024 interventional studies indexed under Stroke.
Browse Stroke studies →Korea University Guro Hospital is the lead sponsor of 89 studies on the registry; 17 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
In addition to 5-session conventional language therapy, we provide a 5-session language rehabilitation program using an AI-based computerized cognitive and language training program. A cognitive evaluation is conducted before starting treatment, and K-Western Aphasia Battery and Functional Near infrared spectroscopy are performed before and after the treatment.
Device: Zenicog;language rehabilitation program · Procedure: Conventional language rehabilitation
We provide a 10-session conventional language therapy. A cognitive evaluation is conducted before starting treatment, and K-Western Aphasia Battery and Functional Near infrared spectroscopy are performed before and after the treatment.
Procedure: Conventional language rehabilitation
This program is an AI-based computerized cognitive and language training program.
Conventional language rahabilitation therapy will apply for all participants with speech impairement
Aphasic quatient
Aphasic quatient using K-Western Aphasia Battery for aphasia assessment tools
Time frame: Evaluate two times ; Before speech therapy treatment program (baseline) and within 7days after the treatment period.
Change of cerebral blood flow
Change of cerebral blood flow with near-infrared spectroscopy
Time frame: Evaluate two times ; Before speech therapy treatment program (baseline) and within 7days after the treatment period.
Ran from Nov 2023 to primary completion in Sep 2024, 9 months.
Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 9 months is below that.
Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 1, 2026: primary completion Dec 2024 → Sep 2024 and completion Dec 2024 → Sep 2024.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Korea University Guro Hospital